Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Do antidepressants cause suicidality in children? A Bayesian meta-analysis.

Kaizar EE, Greenhouse JB, Seltman H, Kelleher K.

Clin Trials. 2006;3(2):73-90; discussion 91-8.

PMID:
16773951
2.

The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.

Seemüller F, Riedel M, Obermeier M, Bauer M, Adli M, Mundt C, Holsboer F, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Jäger M, Henkel V, Möller HJ.

Int J Neuropsychopharmacol. 2009 Mar;12(2):181-9. doi: 10.1017/S1461145708009139. Epub 2008 Jul 29.

PMID:
18662490
3.
4.

Antidepressants use in pediatric populations.

Gören JL.

Expert Opin Drug Saf. 2008 May;7(3):223-5. doi: 10.1517/14740338.7.3.223 .

PMID:
18462180
5.
7.

Newer generation antidepressants for depressive disorders in children and adolescents.

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851. doi: 10.1002/14651858.CD004851.pub3. Review.

PMID:
23152227
9.

Depression, antidepressants and suicidality: a critical appraisal.

Licinio J, Wong ML.

Nat Rev Drug Discov. 2005 Feb;4(2):165-71. Review.

PMID:
15688079
10.

Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration.

Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G.

BMJ. 2009 Aug 11;339:b2880. doi: 10.1136/bmj.b2880. Review.

11.

Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?

Weisberg HI, Hayden VC, Pontes VP.

Clin Trials. 2009 Apr;6(2):109-18. doi: 10.1177/1740774509102563.

PMID:
19342462
12.

Suicidality in pediatric patients treated with antidepressant drugs.

Hammad TA, Laughren T, Racoosin J.

Arch Gen Psychiatry. 2006 Mar;63(3):332-9.

PMID:
16520440
13.

Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement.

Meyer RE, Salzman C, Youngstrom EA, Clayton PJ, Goodwin FK, Mann JJ, Alphs LD, Broich K, Goodman WK, Greden JF, Meltzer HY, Normand SL, Posner K, Shaffer D, Oquendo MA, Stanley B, Trivedi MH, Turecki G, Beasley CM Jr, Beautrais AL, Bridge JA, Brown GK, Revicki DA, Ryan ND, Sheehan DV.

J Clin Psychiatry. 2010 Aug;71(8):e1-e21. doi: 10.4088/JCP.10cs06070blu.

PMID:
20797373
14.

The risks and benefits of antidepressant treatment for youth depression.

Bridge JA, Salary CB, Birmaher B, Asare AG, Brent DA.

Ann Med. 2005;37(6):404-12. Review.

PMID:
16203613
15.
16.

[Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].

Hjalmarsson L, Corcos M, Jeammet P.

Encephale. 2005 May-Jun;31(3):309-16. French.

PMID:
16142045
17.

Antidepressants and suicidality: the basis of controversies.

Marcinko D.

Psychiatr Danub. 2007 Sep;19(3):238-40.

PMID:
17914327
18.

The relationship between antidepressant prescription rates and rate of early adolescent suicide.

Gibbons RD, Hur K, Bhaumik DK, Mann JJ.

Am J Psychiatry. 2006 Nov;163(11):1898-904.

PMID:
17074941
19.

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA.

JAMA. 2007 Apr 18;297(15):1683-96.

PMID:
17440145
20.

The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.

KoKoAung E, Cavenett S, McArthur A, Aromataris E.

JBI Database System Rev Implement Rep. 2015 Apr 17;13(3):174-205. doi: 10.11124/jbisrir-2015-2272. Review.

PMID:
26447056

Supplemental Content

Support Center